Covid-19 (Temas de Saúde Pública)
Ivermectina: como a falsa ciência criou um medicamento “milagroso” para a Covid.
8 Out, 2021 | 12:21hIvermectin: How false science created a Covid ‘miracle’ drug – BBC
Comentário no Twitter
Scientists evaluating ivermectin data for #COVID19
"had not found 'a single clinical trial' claiming to show that ivermectin prevented Covid deaths that did not contain 'either obvious signs of fabrication or errors so critical they invalidate the study'." https://t.co/Xndr6Q5LaS— Isaac Bogoch (@BogochIsaac) October 7, 2021
Bioética | Hospital afirma que pessoas que querem transplante de órgãos devem se vacinar contra a COVID-19.
8 Out, 2021 | 12:20hPeople who want organ transplants must get the COVID-19 vaccine, a hospital say – NPR
Opinião | A Covid-19 segue dando lições sobre o burnout nos profissionais da atenção à saúde. Será que vamos aprendê-las?
8 Out, 2021 | 12:19hCovid-19 keeps delivering lessons about health care worker burnout. Will we learn them? – STAT
Comentário no Twitter
Opinion: Delaying the important work of addressing burnout under the guise of "let's just get through this first" does a disservice to health care workers who need support and relief now. https://t.co/21s5NRvhdk
— STAT (@statnews) October 7, 2021
Estudo observacional no Catar mostrou que a efetividade da vacina da Pfizer contra qualquer infecção por SARS-CoV-2 caiu para 20% entre o 5º e o 7º mês após a segunda dose, mas a efetividade contra Covid-19 grave permaneceu alta.
8 Out, 2021 | 12:04h
Comentário no Twitter
In this 900,000-participant study in Qatar, vaccine effectiveness peaked at 77.5% in the first month after the second dose. The effectiveness fell to as low as 20% in months 5 through 7 after vaccination. #Covid19vaccine #IDTwttier https://t.co/TeDcLLftIH pic.twitter.com/pEBoxs6Hmr
— NEJM (@NEJM) October 6, 2021
Amplo estudo de coorte com mais de 2.5 milhões de indivíduos mostrou que a incidência de miocardite após a vacina da Pfizer foi de 2,13 casos por 100.000 pessoas.
8 Out, 2021 | 12:02hComentário: Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines – TCTMD
Estudo relacionado: Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel – New England Journal of Medicine
Comentários no Twitter
Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000 persons. #Covid19vaccine #IDTwitter https://t.co/EzmsaW2u4Y pic.twitter.com/P95eUm8xo9
— NEJM (@NEJM) October 6, 2021
Just out in @NEJM: Two studies on myocarditis after vaccination with Pfizer
Among 2.5 million vaccinated:
– 54 cases of myocarditis
– 94% men, median 27 y.o.
– Most cases mild, only one fulminanthttps://t.co/xGf7rtwGfr— David Juurlink (@DavidJuurlink) October 6, 2021
Estudo com mais de 5,1 milhões de indivíduos vacinados mostrou que a incidência de miocardite após receberem a vacina da Pfizer foi baixa e mais comum após a segunda dose em homens jovens.
8 Out, 2021 | 12:00hMyocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel – New England Journal of Medicine
Comentário: Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines – TCTMD
Estudo relacionado: Myocarditis after Covid-19 Vaccination in a Large Health Care Organization – New England Journal of Medicine
Comentários no Twitter
In an Israeli Ministry of Health database, 136 cases of myocarditis were detected among 5 million vaccinated persons. #Covid19vaccine #IDTwitter https://t.co/c1wLBCq8UN pic.twitter.com/D2DAGrIuXe
— NEJM (@NEJM) October 6, 2021
Two new @NEJM reports on Pfizer vaccine related myocarditis: very rare (~2 per 100,000) and usually mild; in-depth review of 190 cases, most cases were in males 16-29 years, 2nd dosehttps://t.co/nHgxXTgQ6ohttps://t.co/pchL0VDi4b pic.twitter.com/7pUxNy36Zo
— Eric Topol (@EricTopol) October 6, 2021
Perspectiva | Ninguém está seguro até que todos estejam.
8 Out, 2021 | 11:59hNo one is safe until we are all safe – Science Translational Medicine
Comentário: Covid ‘still running rampant’ worldwide, warns creator of Oxford vaccine – The Guardian
Conteúdo relacionado: Opinion: Vaccine Nationalism Harms Everyone and Protects No One
Comentário no Twitter
No one is safe until we all are safe, by Sarah Gilbert @JennerInstitute @NDMOxford @UniofOxford and @DrRHatchett @CEPIVaccines
With a forecast of global vaccine supply for 2021https://t.co/iUgC6euvz6 @ScienceTM a large proportion are Sinopharm and Sinovac from China pic.twitter.com/w4KfUAsU45— Eric Topol (@EricTopol) October 6, 2021
Suécia e Dinamarca pausam o uso da vacina da Moderna contra COVID-19 em grupos jovens.
8 Out, 2021 | 11:57hSweden, Denmark pause Moderna COVID-19 vaccine for younger age groups – Reuters
Recomendações da EMA sobre doses extras e de reforço das vacinas mRNA da BioNTech/Pfizer e da Moderna.
8 Out, 2021 | 11:26hComirnaty and Spikevax: EMA recommendations on extra doses and boosters – European Medicines Agency
Conteúdo relacionado: The difference between COVID-19 ‘third doses’ and ‘boosters’ – Emory News Center
Comentário no Twitter
EMA recommended additional doses and boosters for #Comirnaty and #Spikevax. https://t.co/qefPg2kMMO
In this context, see below what the difference between an additional dose and a #boosterdose is. pic.twitter.com/HeyOACbWXm
— EU Medicines Agency (@EMA_News) October 5, 2021
Estudo de coorte | Efeitos dos lockdowns ocorridos na pandemia de COVID-19 sobre as cirurgias oncológicas eletivas para 15 tipos de tumores em 61 países.
8 Out, 2021 | 11:25h
Comentário no Twitter (fio – clique para saber mais)
What were the unintended consequences of COVID lockdowns on cancer care?@CovidSurg study in @TheLancetOncol:
🔹Lockdowns independently associated with delayed treatment
🔹At median 5.3 months f/u, 1 in 7 pts had not had planned cancer surgery🆓https://t.co/UZe0euq5kg pic.twitter.com/4fPl6UEb9D
— Dmitri Nepogodiev (@dnepo) October 5, 2021